FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114538891> ?p ?o ?g. }

• W2114538891 endingPage "90" @default.
• W2114538891 startingPage "4383" @default.
• W2114538891 abstract "Recently, an immunocompetent in vivo mouse model was developed based on germ cell alkaline phosphatase (GCAP) transgenic (FVB/N x C3H) mice in which both placental alkaline phosphatase (PLAP)+ and GCAP+ solid MO4 tumors develop. A bispecific anti-PLAP/GCAP anti-mouse CD3 antibody (Ab) 7E8 x 7D6, previously shown to induce efficient dose-dependent T-cell proliferation and PLAP+ tumor cell lysis in the presence of recombinant IL-2 and the anti-mouse CD3 Ab 7D6, was used in this report in in vivo lysis experiments targeting GCAP+ tumors grown in GCAP+ transgenic mice. Mice received injections i.v. twice a week with PBS (group 1) or with 10 micrograms of the bispecific Ab 7E8 x 7D6, either alone (group 2) or combined with 1 microgram of the anti-CD3 Ab 7D6 (group 3), starting 7 days after the tumor inoculation. A fourth group received a local treatment with mouse splenocytes precoated with 10 micrograms 7E8 x 7D6 and 1 microgram 7D6. In between Ab injections, groups 2, 3, and 4 received 10(4) units recombinant IL-2 (i.v.) every day. Two weeks of treatment with the bispecific Ab either alone or combined with 7D6 resulted in a significant decrease of GCAP+ tumor cells in groups 2 and 3 (4 +/- 3% and 10 +/- 11% GCAP+ cells/tumor) as compared to the nontreated tumors (95 +/- 5% GCAP+ cells), although tumor volumes were not significantly different (12 +/- 15 cm3 and 14 +/- 11 cm3 versus 16 +/- 7 cm3). Apparently, the elimination of GCAP+ cells from the tumor seemed to favor conditions enabling the outgrowth of the few GCAP- cells originally present in the tumor inoculate. In contrast, tumor volumes in group 4 (local treatment) were significantly smaller (P < 0.03; 5 +/- 10 cm3, 8 +/- 11% GCAP+ cells) as compared to the nontreated group, probably due to the presence of higher amounts of Ab and infiltrated activated T cells (567 +/- 322 CD5+ cells/mm2) capable of secreting cytostatic cytokines like tumor necrosis factor alpha and IFN-gamma as compared to groups 2 and 3 (266 +/- 135 and 198 +/- 86 CD5+ cells/mm2, respectively). In summary, this study clearly demonstrated that bispecific antibodies specifically concentrate cytotoxic T cells into a solid tumor in vivo, with subsequent elimination of the targeted tumor cell." @default.
• W2114538891 created "2016-06-24" @default.
• W2114538891 creator A5004564353 @default.
• W2114538891 creator A5006329944 @default.
• W2114538891 creator A5035967512 @default.
• W2114538891 creator A5056697942 @default.
• W2114538891 creator A5062958478 @default.
• W2114538891 date "1995-10-01" @default.
• W2114538891 modified "2023-09-23" @default.
• W2114538891 title "Bispecific antibody-mediated lysis of placental and germ cell alkaline phosphatase targeted solid tumors in immunocompetent mice." @default.
• W2114538891 cites W1493845674 @default.
• W2114538891 cites W1495237724 @default.
• W2114538891 cites W1500793474 @default.
• W2114538891 cites W1509169190 @default.
• W2114538891 cites W1565218273 @default.
• W2114538891 cites W1577091908 @default.
• W2114538891 cites W1580399177 @default.
• W2114538891 cites W1902787731 @default.
• W2114538891 cites W1936254860 @default.
• W2114538891 cites W1965307265 @default.
• W2114538891 cites W1982605201 @default.
• W2114538891 cites W1982941068 @default.
• W2114538891 cites W1983059370 @default.
• W2114538891 cites W1989267097 @default.
• W2114538891 cites W1997758678 @default.
• W2114538891 cites W2023236831 @default.
• W2114538891 cites W2038185592 @default.
• W2114538891 cites W2063655292 @default.
• W2114538891 cites W2067640117 @default.
• W2114538891 cites W2071752281 @default.
• W2114538891 cites W2104961116 @default.
• W2114538891 cites W2110544075 @default.
• W2114538891 cites W2111015023 @default.
• W2114538891 cites W2114918609 @default.
• W2114538891 cites W2117925216 @default.
• W2114538891 cites W2130537353 @default.
• W2114538891 cites W2248997616 @default.
• W2114538891 cites W2268837420 @default.
• W2114538891 cites W2401495177 @default.
• W2114538891 cites W2410344289 @default.
• W2114538891 cites W2418787018 @default.
• W2114538891 cites W2437172426 @default.
• W2114538891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7671251" @default.
• W2114538891 hasPublicationYear "1995" @default.
• W2114538891 type Work @default.
• W2114538891 sameAs 2114538891 @default.
• W2114538891 citedByCount "1" @default.
• W2114538891 crossrefType "journal-article" @default.
• W2114538891 hasAuthorship W2114538891A5004564353 @default.
• W2114538891 hasAuthorship W2114538891A5006329944 @default.
• W2114538891 hasAuthorship W2114538891A5035967512 @default.
• W2114538891 hasAuthorship W2114538891A5056697942 @default.
• W2114538891 hasAuthorship W2114538891A5062958478 @default.
• W2114538891 hasConcept C114684123 @default.
• W2114538891 hasConcept C150903083 @default.
• W2114538891 hasConcept C153911025 @default.
• W2114538891 hasConcept C159654299 @default.
• W2114538891 hasConcept C160160445 @default.
• W2114538891 hasConcept C16685009 @default.
• W2114538891 hasConcept C167672396 @default.
• W2114538891 hasConcept C181199279 @default.
• W2114538891 hasConcept C185592680 @default.
• W2114538891 hasConcept C189976730 @default.
• W2114538891 hasConcept C203014093 @default.
• W2114538891 hasConcept C207001950 @default.
• W2114538891 hasConcept C2780025047 @default.
• W2114538891 hasConcept C502942594 @default.
• W2114538891 hasConcept C55493867 @default.
• W2114538891 hasConcept C71924100 @default.
• W2114538891 hasConcept C86803240 @default.
• W2114538891 hasConcept C8891405 @default.
• W2114538891 hasConceptScore W2114538891C114684123 @default.
• W2114538891 hasConceptScore W2114538891C150903083 @default.
• W2114538891 hasConceptScore W2114538891C153911025 @default.
• W2114538891 hasConceptScore W2114538891C159654299 @default.
• W2114538891 hasConceptScore W2114538891C160160445 @default.
• W2114538891 hasConceptScore W2114538891C16685009 @default.
• W2114538891 hasConceptScore W2114538891C167672396 @default.
• W2114538891 hasConceptScore W2114538891C181199279 @default.
• W2114538891 hasConceptScore W2114538891C185592680 @default.
• W2114538891 hasConceptScore W2114538891C189976730 @default.
• W2114538891 hasConceptScore W2114538891C203014093 @default.
• W2114538891 hasConceptScore W2114538891C207001950 @default.
• W2114538891 hasConceptScore W2114538891C2780025047 @default.
• W2114538891 hasConceptScore W2114538891C502942594 @default.
• W2114538891 hasConceptScore W2114538891C55493867 @default.
• W2114538891 hasConceptScore W2114538891C71924100 @default.
• W2114538891 hasConceptScore W2114538891C86803240 @default.
• W2114538891 hasConceptScore W2114538891C8891405 @default.
• W2114538891 hasIssue "19" @default.
• W2114538891 hasLocation W21145388911 @default.
• W2114538891 hasOpenAccess W2114538891 @default.
• W2114538891 hasPrimaryLocation W21145388911 @default.
• W2114538891 hasRelatedWork W1834559088 @default.
• W2114538891 hasRelatedWork W1965641543 @default.
• W2114538891 hasRelatedWork W1999161191 @default.
• W2114538891 hasRelatedWork W2026610770 @default.
• W2114538891 hasRelatedWork W2051579237 @default.

• next